IFF - Conference and earnings call announcements

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE:IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity inte

NEW YORK, May 27, 2024 /PRNewswire/ -- IFF (NYSE:  IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at upcoming major biomedical conferences. These results highlight how IFF Pharma Solutions NovaMatrix® portfolio of ultrapure alginate biopolymers could revolutionize regenerative medicine and 3D cell culture applications. At the 12th World Biomaterials Congress (WBC), IFF Pharma Solutions will showcase a first-of-its-kind alginate hydrogel system that self-gels, offering a minimally invasive way to deliver therapeutics. The company will then reveal how its unique porous alginate foam scaffolds can be utilized for 3D cell cu

IFF Pharma Solutions will shine a light on its technology advancements through its flagship products that demonstrate how timing is everything NEW YORK, May 15, 2024 /PRNewswire/ -- IFF (NYSE:IFF), a global leader in food and beverage, home and personal care and health, today announced a new controlled release platform for its portfolio of controlled release products including METHOCEL™, ETHOCEL™, and POLYOX™.  Under the banner, "Timing is Everything," the platform provides comprehensive solutions for pharmaceutical therapies to benefit patients and highlights the importance of controlled release of active ingredients and improving patient compliance. Complete with educational materials for

IFF (NYSE:IFF) announced today that the Company's management will speak at the Consumer Analyst Group of New York (CAGNY) conference in Boca Raton, Florida, on Thursday, Feb. 23 at 1:00 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of s

IFF (NYSE:IFF) announced today that Executive Vice President and Chief Financial Officer Glenn Richter will be a featured speaker at the Consumer Analyst Group of New York's annual conference, to be held virtually on Thursday, Feb. 24, 2022. A pre-recorded webcast of his presentation is scheduled to begin at 3:00 p.m. ET. Following the session, a replay will be accessible at ir.iff.com. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an i

WILMINGTON, Del., Oct. 21, 2021 /PRNewswire-PRWeb/ -- Backed by 300 years of combined cellulosic excipient experience, including leading brands like Avicel® and METHOCEL™, a robust seaweed-based excipient portfolio and deep technical expertise, IFF's Pharma Solutions will reaffirm its commitment to helping customers globally deliver consistent, high-quality products at this year's CPhI Worldwide and CPhI China. Attendees at CPhI Worldwide can connect with IFF's experts at stand 7G21 from Nov. 9 to 11 in Milan, or virtually from Oct. 25 to Nov. 19. Both physical and virtual visitors will be able to explore highly customized excipient solutions to address their current formulation challenges,

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today that Chairman & Chief Executive Officer Andreas Fibig will be a featured speaker at the Consumer Analyst Group of New York's annual conference, to be held virtually on Wednesday, Feb. 17, 2021. A pre-recorded webcast of their presentation is scheduled to begin at 10:40 a.m. ET. Following the session, a replay will be accessible at ir.iff.com. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and sensorial experiences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art an